Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
OTC Trading Sector Focus List: Abakan, Inc. MyECheck, Inc. Easton Pharmaceuticals, MRI Interventions, Infinex Ventures PR Newswire LONDON, June 4, 2014 LONDON, June 4, 2014 /PRNewswire/...
OTC Sector Trading Focus List: GrowBlox Sciences, Inc., Amarantus Bioscience Holdings, Inc., Plandai Biotechnology, Inc., Limitless Venture Group, Inc., Infinex Ventures, Inc. PR Newswire LONDON...
In TO129, "Infinex Ventures Inc. - Update On Agreement With Property In Chile", transmitted on June 14 at 11:19e, the "Vendors" should have been identified as "Jorge Lopehandia, The Lopehandia...
Trading Symbol: INFX: OB LAS VEGAS, NV, June 14 /PRNewswire-FirstCall/ -- Infinex Ventures Inc. (OTCBB:INFX) is pleased to announce that on January 30, 2006, we entered into an agreement...
Trading Symbol: INFX: OB LAS VEGAS, NV, May 9 /PRNewswire-FirstCall/ -- Infinex Ventures Inc. (INFX:OB - News; "the Company") and its Board of Directors are pleased to announce that the Company...
Trading Symbol: INFX: OB LAS VEGAS, May 5 /PRNewswire-FirstCall/ -- Infinex Ventures Inc. (IFNX:OB - "the Company") and its Board of Directors are please to announce that the Company has been...
Trading Symbol: INFX: OB LAS VEGAS, April 20 /PRNewswire-FirstCall/ -- Infinex Ventures Inc. ("the Company") and its Board of Directors are pleased to announce that its Symbol change ("INFX...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 550 | 1.0E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 471 | 1.0E-6 | CS |
| 156 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 3509 | 1.0E-6 | CS |
| 260 | -9.9E-5 | -99 | 0.0001 | 0.005 | 1.0E-6 | 29669 | 0.00101103 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
